Leukemia & Lymphoma, Volume 56, Issue 8 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 56, Issue 8 (2015)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Volume 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries on selected articles in this issue

Article Commentary
Stage I-II follicular lymphoma: an endangered species?
Peter McLaughlin & John F. Seymour
Pages: 2229-2230
Published online: 23 Sep 2015
CitationforStage I-II follicular lymphoma: an endangered species? | Full Text | References | PDF (123.8 KB) | Supplemental
  • 215 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Enhancing monoclonal antibody activity in chronic lymphocytic leukemia
James B. Johnston
Pages: 2231-2232
Published online: 06 Aug 2015
CitationforEnhancing monoclonal antibody activity in chronic lymphocytic leukemia | Full Text | References | PDF (123.5 KB)
  • 80 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
A new “age” for high dose therapy and autologous stem cell transplant
Adrienne A. Phillips & Koen van Besien
Pages: 2233-2234
Published online: 02 Mar 2015
CitationforA new “age” for high dose therapy and autologous stem cell transplant | Full Text | References | PDF (122.9 KB) | Supplemental
  • 147 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Defining vulnerability in allogeneic transplants is more complicated than the two numerical digits of age
Mohamed L. Sorror
Pages: 2235-2236
Published online: 20 May 2015
CitationforDefining vulnerability in allogeneic transplants is more complicated than the two numerical digits of age | Full Text | References | PDF (121 KB) | Supplemental
  • 77 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Rituximab and glucocorticoids: friends or foes? It is all about timing
Shuo Ma & Leonidas C. Platanias
Pages: 2237-2238
Published online: 14 Mar 2015
CitationforRituximab and glucocorticoids: friends or foes? It is all about timing | Full Text | References | PDF (118.2 KB) | Supplemental
  • 125 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Structural genomic alterations in primary mediastinal large B-cell lymphoma
David D. W. Twa & Christian Steidl
Pages: 2239-2250
Published online: 21 Jan 2015
AbstractforStructural genomic alterations in primary mediastinal large B-cell lymphoma | Full Text | References | PDF (1.8 MB) | Supplemental
  • 771 Views
  • 17 CrossRef citations
  • 0Altmetric
Review Article
Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets
Ibrahim H. Younos, Fuminori Abe & James E. Talmadge
Pages: 2251-2263
Published online: 21 Jan 2015
AbstractforMyeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets | Full Text | References | PDF (578.6 KB) | Supplemental
  • 523 Views
  • 17 CrossRef citations
  • 0Altmetric
Review Article
Novel therapeutic options for relapsed hairy cell leukemia
Preetesh Jain, Aaron Polliack & Farhad Ravandi
Pages: 2264-2272
Published online: 04 Feb 2015
AbstractforNovel therapeutic options for relapsed hairy cell leukemia | Full Text | References | PDF (499.2 KB) | Supplemental
  • 784 Views
  • 10 CrossRef citations
  • 0Altmetric
Review Article
Asparaginase pharmacokinetics and implications of therapeutic drug monitoring
Barbara Asselin & Carmelo Rizzari
Pages: 2273-2280
Published online: 11 Mar 2015
AbstractforAsparaginase pharmacokinetics and implications of therapeutic drug monitoring | Full Text | References | PDF (260.4 KB) | Supplemental
  • 5490 Views
  • 103 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
Prognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia
Sanja Prijić, Ivo Ugrina, Boris Labar, Damir Nemet, Josip Batinić, Renata Zadro, Sunčica Ries, Koraljka Gjadrov-Kuvedžić, Sanja Davidović & Drago Batinić
Pages: 2281-2288
Published online: 29 Dec 2014
AbstractforPrognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia | Full Text | References | PDF (794.3 KB) | Supplemental
  • 205 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Prognostic importance of expression of the Wilms’ tumor 1 gene in newly diagnosed acute promyelocytic leukemia
Anna Hecht, Florian Nolte, Daniel Nowak, Verena Nowak, Mark Reinwald, Benjamin Hanfstein, Andreas Faldum, Thomas Büchner, Karsten Spiekermann, Cristina Sauerland, Christel Weiss, Wolf-Karsten Hofmann & Eva Lengfelder
Pages: 2289-2295
Published online: 21 Jan 2015
AbstractforPrognostic importance of expression of the Wilms’ tumor 1 gene in newly diagnosed acute promyelocytic leukemia | Full Text | References | PDF (496 KB) | Supplemental
  • 223 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Trends in survival outcomes of B-lineage acute lymphoblastic leukemia in elderly patients: analysis of Surveillance, Epidemiology, and End Results database
Guru Subramanian Guru Murthy, Raji Venkitachalam & Paulette Mehta
Pages: 2296-2300
Published online: 21 Jan 2015
AbstractforTrends in survival outcomes of B-lineage acute lymphoblastic leukemia in elderly patients: analysis of Surveillance, Epidemiology, and End Results database | Full Text | References | PDF (387 KB) | Supplemental
  • 313 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Preferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology
Young-Uk Cho, Seongsoo Jang, Eul-Ju Seo, Chan-Jeoung Park, Hyun-Sook Chi, Dae-Young Kim, Jung-Hee Lee, Je-Hwan Lee, Kyoo-Hyung Lee, Kyung-Nam Koh, Ho-Joon Im, Jong Jin Seo, Sang Hyuk Park, Young-Mi Park & Jong-Keuk Lee
Pages: 2301-2308
Published online: 21 Jan 2015
AbstractforPreferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology | Full Text | References | PDF (1.1 MB) | Supplemental
  • 702 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment
Joanna Gora-Tybor, Ewa Medras, Malgorzata Calbecka, Agnieszka Kolkowska-Leśniak, Edyta Ponikowska-Szyba, Tadeusz Robak & Krzysztof Jamroziak
Pages: 2309-2314
Published online: 05 Mar 2015
AbstractforReal-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment | Full Text | References | PDF (259.5 KB) | Supplemental
  • 958 Views
  • 27 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
Ursula Rochau, Gaby Sroczynski, Dominik Wolf, Stefan Schmidt, Beate Jahn, Martina Kluibenschaedl, Annette Conrads-Frank, David Stenehjem, Diana Brixner, Jerald Radich, Günther Gastl & Uwe Siebert
Pages: 2315-2325
Published online: 14 Jan 2015
AbstractforCost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia | Full Text | References | PDF (661.7 KB) | Supplemental
  • 721 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia
Sylvain P. Chantepie, Emilie Reboursiere, Jean-Baptiste Mear, Anne-Claire Gac, Veronique Salaun, Khaled Benabed, Stéphane Cheze, Hyacinthe Johnsonansah, Margaret Macro, Jean-Pierre Vilque & Oumedaly Reman
Pages: 2326-2330
Published online: 21 Jan 2015
AbstractforGemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia | Full Text | References | PDF (197 KB) | Supplemental
  • 645 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study
Bozena Katarzyna Budziszewska, Agnieszka Pluta, Kazimierz Sulek, Agnieszka Wierzbowska, Tadeusz Robak, Sebastian Giebel, Aleksandra Holowiecka-Goral, Waldemar Sawicki, Anna Ejduk, Elzbieta Patkowska, Joanna Manko, Justyna Gajkowska-Kulik, Jaroslaw Piszcz, Monika Mordak-Domagala, Krzysztof Madry, Jerzy Holowiecki, Slawomira Kyrcz-Krzemien, Maria Nowakowska-Domagala, Anna Dmoszynska, Malgorzata Calbecka, Janusz Kloczko, Wiesław Wiktor Jędrzejczak, Andrzej Lange, Malgorzata Razny, Przemyslaw Bilinski, Krzysztof Warzocha & Ewa Lech-Maranda
Pages: 2331-2338
Published online: 21 Jan 2015
AbstractforTreatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study | Full Text | References | PDF (285.4 KB) | Supplemental
  • 412 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Changes in the use of radiation therapy for early classical Hodgkin lymphoma in adolescents and young adults: implications for survival and second malignancies
Ana C. Xavier & Luciano J. Costa
Pages: 2339-2343
Published online: 21 Jan 2015
AbstractforChanges in the use of radiation therapy for early classical Hodgkin lymphoma in adolescents and young adults: implications for survival and second malignancies | Full Text | References | PDF (245.9 KB) | Supplemental
  • 289 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Thymic hyperplasia following chemotherapy in adults with lymphoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings and correlation with T cell repopulation
Dao-Ping Sun, Chong-Yang Ding, Li Wang, Jin-Hua Liang, Lei Fan, Yu-Jie Wu, Tian Tian, Tian-Nv Li, Wei Xu & Jian-Yong Li
Pages: 2344-2349
Published online: 21 Jan 2015
AbstractforThymic hyperplasia following chemotherapy in adults with lymphoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings and correlation with T cell repopulation | Full Text | References | PDF (572.8 KB) | Supplemental
  • 165 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
Andrea Janikova, Zbynek Bortlicek, Vit Campr, Natasa Kopalova, Katerina Benesova, David Belada, Vit Prochazka, Robert Pytlik, Samuel Vokurka, Jan Pirnos, Juraj Duras, Heidi Mocikova, Jiri Mayer & Marek Trneny
Pages: 2350-2356
Published online: 21 Jan 2015
AbstractforRadiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy? | Full Text | References | PDF (226.3 KB) | Supplemental
  • 663 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B
Chia-Yun Wu, Liang-Tsai Hsiao, Tzeon-Jye Chiou, Jyh-Pyng Gau, Jin-Hwang Liu, Yuan-Bin Yu, Yi-Tsui Wu, Chia-Jen Liu, Yu-Chung Huang, Man-Hsin Hung, Po-Min Chen, Yi-Hsiang Huang & Cheng-Hwai Tzeng
Pages: 2357-2364
Published online: 21 Jan 2015
AbstractforLymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B | Full Text | References | PDF (264.2 KB) | Supplemental
  • 288 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Relationships between chemotherapy, chemotherapy dose intensity and outcomes of follicular lymphoma in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence Molecular Epidemiology Resource
Kitsada Wudhikarn, Brian J. Smith, Anna M. Button, Thomas M. Habermann, Carrie A. Thompson, Lori J. Rosenstein, Sergei I. Syrbu, George J. Weiner, James R. Cerhan & Brian K. Link
Pages: 2365-2372
Published online: 09 Feb 2015
AbstractforRelationships between chemotherapy, chemotherapy dose intensity and outcomes of follicular lymphoma in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence Molecular Epidemiology Resource | Full Text | References | PDF (444.3 KB) | Supplemental
  • 298 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates
Clive S. Zent, Timothy G. Call, Deborah A. Bowen, Michael J. Conte, Betsy R. LaPlant, Thomas E. Witzig, Stephen M. Ansell & George J. Weiner
Pages: 2373-2378
Published online: 17 Mar 2015
AbstractforEarly treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates | Full Text | References | PDF (191.2 KB) | Supplemental
  • 341 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma
Nicolas Martin, Delphine Borchiellini, Diane Coso, Lauris Gastaud, Annick Boscagli, Laurence Saudes, Daniel Re, Jean Gutnecht, Georges Garnier, Emmanuel Petit, Jèrôme Barriere, Hervé Naman, Benoit Rossignol, Antoine Thyss & Frederic Peyrade
Pages: 2379-2387
Published online: 20 Feb 2015
AbstractforHigh-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma | Full Text | References | PDF (823.2 KB) | Supplemental
  • 499 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Impact of disease status on outcome in relapsed and refractory multiple myeloma treated with lenalidomide
Chiara Nozzoli, Michela Staderini, Alessio Veltroni, Giovanni Longo, Francesca Bacchiarri, Irene Donnini, Agata Guarrera & Alberto Bosi
Pages: 2388-2391
Published online: 09 Feb 2015
AbstractforImpact of disease status on outcome in relapsed and refractory multiple myeloma treated with lenalidomide | Full Text | References | PDF (554.7 KB) | Supplemental
  • 638 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Age influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-host disease of varying severity following allogeneic hematopoietic cell transplant
Takahiko Nakane, Takahiro Fukuda, Junya Kanda, Shuichi Taniguchi, Tetsuya Eto, Kazuteru Ohashi, Hirohisa Nakamae, Mineo Kurokawa, Takehiko Mori, Yasuo Morishima, Tokiko Nagamura-Inoue, Hisashi Sakamaki, Yoshiko Atsuta & Makoto Murata
Pages: 2392-2397
Published online: 09 Feb 2015
AbstractforAge influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-host disease of varying severity following allogeneic hematopoietic cell transplant | Full Text | References | PDF (412.9 KB) | Supplemental
  • 148 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Flavokawain B inhibits the growth of acute lymphoblastic leukemia cells via p53 and caspase-dependent mechanisms
Yan-Lai Tang, Li-Bin Huang, Yun Tian, Li-Na Wang, Xiao-Li Zhang, Zhi-Yong Ke, Wu-Guo Deng & Xue-Qun Luo
Pages: 2398-2407
Published online: 23 Feb 2015
AbstractforFlavokawain B inhibits the growth of acute lymphoblastic leukemia cells via p53 and caspase-dependent mechanisms | Full Text | References | PDF (1.4 MB) | Supplemental
  • 351 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Epstein–Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype
Siok-Bian Ng, Koichi Ohshima, Viknesvaran Selvarajan, Gaofeng Huang, Shoa-Nian Choo, Hiroaki Miyoshi, Norio Shimizu, Renji Reghunathan, Hsin-Chieh Chua, Allen Eng-Juh Yeoh, Thuan-Chong Quah, Liang-Piu Koh, Poh-Lin Tan & Wee-Joo Chng
Pages: 2408-2415
Published online: 21 Jan 2015
AbstractforEpstein–Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype | Full Text | References | PDF (1.7 MB) | Supplemental
  • 495 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
ETV6/ARG oncoprotein confers autonomous cell growth by enhancing c-Myc expression via signal transducer and activator of transcription 5 activation in the acute promyelocytic leukemia cell line HT93A
Noriyoshi Iriyama, Yoshihiro Hatta & Masami Takei
Pages: 2416-2423
Published online: 04 Dec 2014
AbstractforETV6/ARG oncoprotein confers autonomous cell growth by enhancing c-Myc expression via signal transducer and activator of transcription 5 activation in the acute promyelocytic leukemia cell line HT93A | Full Text | References | PDF (1.5 MB) | Supplemental
  • 200 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias
Deepesh P. Lad, Subhash Varma, Neelam Varma, Man Updesh Singh Sachdeva, Parveen Bose & Pankaj Malhotra
Pages: 2424-2428
Published online: 21 Jan 2015
AbstractforRegulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias | Full Text | References | PDF (373 KB) | Supplemental
  • 615 Views
  • 30 CrossRef citations
  • 0Altmetric
Article
Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma
Yi-Wen Zhang, Jie Zhang, Jun Li, Jun-Feng Zhu, Yan-Li Yang, Li-Li Zhou, Zhong-Li Hu & Feng Zhang
Pages: 2429-2438
Published online: 21 Jan 2015
AbstractforMethylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma | Full Text | References | PDF (2.2 MB) | Supplemental
  • 218 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia
Sanne H. Tonino, Chantal E. Mulkens, Jacoline van Laar, Ingrid A. M. Derks, Guangli Suo, Fransien Croon-de Boer, Marinus H. J. van Oers, Eric Eldering, Jean Y. Wang & Arnon P. Kater
Pages: 2439-2447
Published online: 21 Jan 2015
AbstractforInduction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia | Full Text | References | PDF (508.8 KB) | Supplemental
  • 188 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Rituximab-induced early and late signaling have opposite effects on dexamethasone-induced apoptosis in human follicular lymphoma cells
Jemal Adem, Antti Ropponen, Jonna Eeva, Mine Eray, Jukka Pelkonen & Ulla Nuutinen
Pages: 2448-2457
Published online: 24 Feb 2015
AbstractforRituximab-induced early and late signaling have opposite effects on dexamethasone-induced apoptosis in human follicular lymphoma cells | Full Text | References | PDF (1.5 MB) | Supplemental
  • 176 Views
  • 3 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Lenalidomide differently modulates CD20 antigen surface expression on chronic lymphocytic leukemia B-cells
Giovanni D’Arena, Vitalba Ruggieri, Fiorella D’Auria, Francesco La Rocca, Vittorio Simeon, Teodora Statuto, Antonella Caivano, Donatella Telesca, Luigi Del Vecchio & Pellegrino Musto
Pages: 2458-2459
Published online: 29 Jan 2015
CitationforLenalidomide differently modulates CD20 antigen surface expression on chronic lymphocytic leukemia B-cells | Full Text | References | PDF (123.7 KB) | Supplemental
  • 296 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Possible implication of IKAROS gene deletion and BCR–ABL1 variants in progression of chronic myeloid leukemia to lymphoid blast crisis in childhood: a single-institution experience
Maria Moschovi, Maria Adamaki, Anastasia Athanasiadou, Aspasia Divane, Anna Karytianou & Natalia Tourkantoni
Pages: 2460-2462
Published online: 17 Feb 2015
First Page PreviewforPossible implication of IKAROS gene deletion and BCR–ABL1 variants in progression of chronic myeloid leukemia to lymphoid blast crisis in childhood: a single-institution experience | Full Text | References | PDF (403.4 KB) | Supplemental
  • 127 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
A case of acute erythroleukemia with concurrence of BCR–ABL and FLT3-TKD (D835E) mutation
Wenxiu Cheng, Xiaofei Yang, Nana Ping, Suning Chen & Aining Sun
Pages: 2463-2464
Published online: 11 Feb 2015
CitationforA case of acute erythroleukemia with concurrence of BCR–ABL and FLT3-TKD (D835E) mutation | Full Text | References | PDF (843.5 KB) | Supplemental
  • 120 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions
Elisabeth Hinterseer, Olga Stiefel, Daniel Neureiter, Gabriele Kandler, Stefan Vogt, Josef Hutter, Gertraud Strasser, Richard Greil, Tanja Nicole Hartmann & Georg Hopfinger
Pages: 2465-2467
Published online: 09 Feb 2015
First Page PreviewforVLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions | Full Text | References | PDF (4.5 MB) | Supplemental
  • 1361 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Letter
Temozolomide-associated myelodysplasia 6 years after treatment of a patient with pancreatic neuroendocrine tumor
Armin Rashidi & Steven M. Sorscher
Pages: 2468-2469
Published online: 21 Jan 2015
CitationforTemozolomide-associated myelodysplasia 6 years after treatment of a patient with pancreatic neuroendocrine tumor | Full Text | References | PDF (120.6 KB) | Supplemental
  • 157 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Concomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomalies
Nahid M. Nanaji, Qing C. Chen, Zeba Singh, Douglas D. Ross, Ari H. Elman & Ying S. Zou
Pages: 2470-2472
Published online: 24 Feb 2015
First Page PreviewforConcomitant bone marrow involvement by plasma cell myeloma and primary myelodysplastic syndrome with biclonal complex chromosome anomalies | Full Text | References | PDF (401.8 KB) | Supplemental
  • 138 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Methylenetetrahydrofolate reductase polymorphism has no differential effect on the outcome of allogeneic hematopoietic stem cell transplant
Michael Koldehoff & Dietrich W. Beelen
Pages: 2473-2475
Published online: 09 Feb 2015
First Page PreviewforMethylenetetrahydrofolate reductase polymorphism has no differential effect on the outcome of allogeneic hematopoietic stem cell transplant | Full Text | References | PDF (129.6 KB) | Supplemental
  • 55 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma
Tarec C. El-Galaly, Anders E. Bilgrau, Eva Gaarsdal, Tobias W. Klausen, Lars M. Pedersen, Kaspar R. Nielsen, John Bæch, Martin Bøgsted, Karen Dybkær, Julia S. Johansen & Hans E. Johnsen
Pages: 2476-2478
Published online: 24 Feb 2015
First Page PreviewforCirculating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma | Full Text | References | PDF (125.7 KB) | Supplemental
  • 172 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Evidence for long-term hypercoagulopathy, but normalization of markers of extracellular matrix turnover, in patients with non-Hodgkin lymphoma
Per O. Iversen, Helene Negaard, Bjørn Østenstad, Per M. Sandset & Svein O. Kolset
Pages: 2479-2481
Published online: 12 Jun 2013
First Page PreviewforEvidence for long-term hypercoagulopathy, but normalization of markers of extracellular matrix turnover, in patients with non-Hodgkin lymphoma | Full Text | References | PDF (162.6 KB) | Supplemental
  • 72 Views
  • 1 CrossRef citations
  • 0Altmetric

Short Communication

Not all CALR mutations are created equal
Rong He, Curtis A. Hanson, Dong Chen, Jennifer L. Oliveira, Animesh Pardanani, Kaaren K. Reichard & David S. Viswanatha
Pages: 2482-2483
Published online: 21 Aug 2015
CitationforNot all CALR mutations are created equal | Full Text | References | PDF (519.5 KB) | Supplemental
  • 480 Views
  • 4 CrossRef citations
  • 0Altmetric
Dasatinib-induced immunosuppression and recurrent respiratory tract infections
Faruk Obut, Nicole Randall, Jo-Anne H. Young, Peter Valent & Celalettin Ustun
Pages: 2484-2485
Published online: 21 Jan 2015
CitationforDasatinib-induced immunosuppression and recurrent respiratory tract infections | Full Text | References | PDF (122.7 KB) | Supplemental
  • 272 Views
  • 6 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles